Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cyfuse Biomedical K.K. (JP:4892)
TSE/TYO:4892
Holding JP:4892?
Track your performance easily
4892 Stock Chart & Stats
Day’s Range¥0 - ¥0
52-Week Range¥512.00 - ¥883.00
Previous Close¥588
Volume12.70K
Average Volume (3M)150.12K
Market Cap
¥4.78B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.57
Next Earnings
Nov 12, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-84.87
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume150,119
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
4892 FAQ
What was Cyfuse Biomedical K.K.’s price range in the past 12 months?
Cyfuse Biomedical K.K. lowest stock price was ¥512.00 and its highest was ¥883.00 in the past 12 months.
What is Cyfuse Biomedical K.K.’s market cap?
Currently, no data Available
When is Cyfuse Biomedical K.K.’s upcoming earnings report date?
Cyfuse Biomedical K.K.’s upcoming earnings report date is Nov 12, 2024 which is in 52 days.
How were Cyfuse Biomedical K.K.’s earnings last quarter?
Cyfuse Biomedical K.K. released its earnings results on Aug 14, 2024. The company reported -¥27.77 earnings per share for the quarter, missing the consensus estimate of N/A by -¥27.77.
Is Cyfuse Biomedical K.K. overvalued?
According to Wall Street analysts Cyfuse Biomedical K.K.’s price is currently Overvalued.
Does Cyfuse Biomedical K.K. pay dividends?
Cyfuse Biomedical K.K. does not currently pay dividends.
What is Cyfuse Biomedical K.K.’s EPS estimate?
Cyfuse Biomedical K.K.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cyfuse Biomedical K.K. have?
Cyfuse Biomedical K.K. has 8,131,800 shares outstanding.
What happened to Cyfuse Biomedical K.K.’s price movement after its last earnings report?
Cyfuse Biomedical K.K. reported an EPS of -¥27.77 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.318%.
Which hedge fund is a major shareholder of Cyfuse Biomedical K.K.?
Currently, no hedge funds are holding shares in JP:4892
---
Technical Analysis
Tsubota Laboratory Incorporated
―
MUROMACHI CHEMICALS INC.
―
STELLA PHARMA CORPORATION
―
Renascience Inc.
―
---